stars 1 stars 2 stars 3

Life-threatening diseases require precision at the cellular level. Qtas brings quantum sensing to single-cell analysis, delivering an entirely new understanding of disease. Our platform is the world's smallest MRI, designed specifically for pharma, clinical, and translational research workflows. It recovers rare cells one by one directly in native blood or cerebrospinal fluid to identify disease long before it shows up on a scan. Starting with oncology, our ambition is to pave the way to a new generation of precision medicine across prenatal health, cardiovascular disease, and drug development. By revealing richer biological insights hidden by bulk and population-average measurements, Qtas leads to faster diagnostics, more effective treatment monitoring, and better outcomes for each patient. Behind every cell is a patient. Behind every patient is a life worth fighting for. Let's make personalised medicine a standard. Not for some. For all.

Website http://www.qtas.com
Employees 6 (6 on RocketReach)
Founded 2025
Address Lichtenbergstraße, Garching, Bavaria 85748, DE
Industry Research

QTAS Questions

Robin Allert is the CEO and Co-Founder of QTAS.

6 people are employed at QTAS.

QTAS is based in Garching, Bavaria.

Top QTAS Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users